Copyright
©The Author(s) 1997.
World J Gastroenterol. Jun 15, 1997; 3(2): 104-107
Published online Jun 15, 1997. doi: 10.3748/wjg.v3.i2.104
Published online Jun 15, 1997. doi: 10.3748/wjg.v3.i2.104
Factors | n | Survival rate (%) | |||
6 mo | 12 mo | 24 mo | 36 mo | ||
Clinical stages | |||||
II | 112 | 88 | 60 | 33 | 19 |
III | 68 | 53 | 17 | 0 | |
Pathological types | |||||
Nodulous | 28 | 83 | 53 | 24 | 19 |
Massive | 128 | 77 | 48 | 27 | 15 |
Diffusive | 32 | 56 | 23 | 0 | |
Mass diameter (cm) | |||||
< 5 | 10 | 100 | 100 | 62 | 54 |
5-10 | 78 | 85 | 61 | 32 | 18 |
≥ 10 | 100 | 66 | 29 | 11 | 0 |
Treatment time | |||||
1 | 58 | 45 | 0 | ||
2 | 48 | 79 | 48 | 23 | 0 |
> 2 | 82 | 95 | 78 | 39 | 26 |
Tumor thrombi | |||||
(+) | 96 | 65 | 28 | 3 | 0 |
(-) | 92 | 87 | 65 | 39 | 23 |
Liver cirrhosis | |||||
None or mild | 109 | 87 | 68 | 39 | 24 |
Moderate or severe | 79 | 39 | 18 | 4 | 0 |
- Citation: Zheng CS, Feng GS, Zhou RM, Liang B, Liang HM, Zhen J, Yu JM, Liu H. Hepatic arterial infusion chemotherapy and embolization in the treatment of primary hepatic carcinoma. World J Gastroenterol 1997; 3(2): 104-107
- URL: https://www.wjgnet.com/1007-9327/full/v3/i2/104.htm
- DOI: https://dx.doi.org/10.3748/wjg.v3.i2.104